7 results
Summary of the therapeutic uses of adrenergic agonists
Table of Catecholamine Pressors, Non-Catecholamines, Alpha and Beta Receptor
Summary of the therapeutic ... uses of adrenergic ... agonists Table ... #Pharmacology ... #Alpha #Beta #Table
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... Ozempic), or daily tablet ... #Summary #DM2 # ... diabetes #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... #Summary #DM2 # ... diabetes #endocrinology
Summary of β-adrenergic antagonists
 - Propranolol - Beta1, Beta2 - Hypertension, Migraine, Hyperthyroidism, Angina pectoris 
-
Summary of β-adrenergic ... #BetaBlockers #Pharmacology ... #Table #Uses #Applications
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
been reported to cause ... are listed in Table ... to be the most frequent ... cause of drug-induced ... #Pharmacology #Drugs